COLLEGE STATION, TX – A new frontier in medical science has been unlocked, promising a future where cancer treatment is as simple as enjoying a double-shot latte. Scientists at Texas A&M have developed a revolutionary CRISPR-based therapy that requires patients to activate their own gene-editing cells by consuming caffeine, but only if they're in the right frame of mind.

“We found that the therapeutic T-cells, while incredibly potent, were also incredibly sensitive to the patient’s overall energy and mood,” explained Dr. Brenda Putter, lead researcher and self-proclaimed 'coffee enthusiast.' “If you’re chugging a cold brew while stressed about your commute, the cells just refuse to work. They need good vibes. They need that gentle, focused buzz, not a panic attack.”

The innovative approach, dubbed 'Chemogenetic Chill-Outs,' allows cells to be programmed in advance and then activated by a small dose of caffeine from coffee, chocolate, or even certain artisanal sodas. However, a mandatory pre-treatment survey assesses the patient’s 'caffeine-to-anxiety ratio' to ensure optimal cellular receptivity.

“It’s about holistic healing,” added Dr. Putter. “We’re not just fighting cancer; we’re fighting the existential dread that prevents the fight. Our cells are basically tiny, highly-educated baristas.” Future research aims to determine if the cells also require a specific Spotify playlist to perform at peak efficiency.

Patients are now being encouraged to practice mindfulness and cultivate a deep appreciation for their morning ritual, because apparently, their immune system is judging them.